<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37297812</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Clustering Analysis Identified Three Long COVID Phenotypes and Their Association with General Health Status and Working Ability.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3617</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12113617</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">This study aimed to distinguish different phenotypes of long COVID through the post-COVID syndrome (PCS) score based on long-term persistent symptoms following COVID-19 and evaluate whether these symptoms affect general health and work ability. In addition, the study identified predictors for severe long COVID.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">This cluster analysis included cross-sectional data from three cohorts of patients after COVID-19: non-hospitalized (n = 401), hospitalized (n = 98) and those enrolled at the post-COVID outpatient's clinic (n = 85). All the subjects responded to the survey on persistent long-term symptoms and sociodemographic and clinical factors. K-Means cluster analysis and ordinal logistic regression were used to create PCS scores that were used to distinguish patients' phenotypes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">506 patients with complete data on persistent symptoms were divided into three distinct phenotypes: none/mild (59%), moderate (22%) and severe (19%). The patients with severe phenotype, with the predominating symptoms were fatigue, cognitive impairment and depression, had the most reduced general health status and work ability. Smoking, snuff, body mass index (BMI), diabetes, chronic pain and symptom severity at COVID-19 onset were factors predicting severe phenotype.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggested three phenotypes of long COVID, where the most severe was associated with the highest impact on general health status and working ability. This knowledge on long COVID phenotypes could be used by clinicians to support their medical decisions regarding prioritizing and more detailed follow-up of some patient groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kisiel</LastName><ForeName>Marta A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, 751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seika</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Care Sciences and Society, Primary Care Medicine, Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malmquist</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0002-1404-9721</Identifier><AffiliationInfo><Affiliation>Department of Statistics, Uppsala University, 751 20 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rykatkin</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Statistics, Uppsala University, 751 20 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holgert</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, 751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janols</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, Infection Disease, Uppsala University, 751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janson</LastName><ForeName>Christer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, 751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xingwu</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9831-9102</Identifier><AffiliationInfo><Affiliation>Department of Statistics, Uppsala University, 751 20 Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, 751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences: Clinical Physiology, Uppsala University, 751 85 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022</GrantID><Agency>&#xc5;ke Wibergs Stiftelse</Agency><Country/></Grant><Grant><GrantID>2022</GrantID><Agency>Lars Hiertas Minne Stiftelse</Agency><Country/></Grant><Grant><GrantID>2022</GrantID><Agency>Sven och Dagmar Sal&#xe9;n Stiftelse</Agency><Country/></Grant><Grant><GrantID>2021</GrantID><Agency>Tore Nilsons Stiftelsen</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">general health status</Keyword><Keyword MajorTopicYN="N">long COVID phenotypes</Keyword><Keyword MajorTopicYN="N">persistent long-term symptoms</Keyword><Keyword MajorTopicYN="N">working ability</Keyword></KeywordList><CoiStatement>All authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37297812</ArticleId><ArticleId IdType="pmc">PMC10253616</ArticleId><ArticleId IdType="doi">10.3390/jcm12113617</ArticleId><ArticleId IdType="pii">jcm12113617</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Post COVID-19 Condition. 2022.  [(accessed on 10 May 2023)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2021;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  At Least 17 Million People in the WHO European Region Experienced Long COVID in the FIRST Two Years of the Pandemic; Millions May Have to Live with It for Years to Come 2022.  [(accessed on 10 May 2023)].  Available online:  https://www.who.int/europe/news/item/13-09-2022-at-least-17-million-people-in-the-who-european-region-experienced-long-covid-in-the-first-two-years-of-the-pandemic--millions-may-have-to-live-with-it-for-years-to-come.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing TK P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Zhang L., Elb&#xe9;ji A., Wilmes P., Oustric P., Staub T., Nazarov P.V., Ollert M., Fagherazzi G. Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity. Open Forum Infect. Dis. 2022;9:ofac397. doi: 10.1093/ofid/ofac397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Le Shi L., Jiang Z., Na Zeng N., Mei H., Lu Y., Yang J., Jin F., Ni S., Wu S., et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol. Psychiatry. 2023:1&#x2013;9. doi: 10.1038/s41380-023-01951-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-01951-1</ArticleId><ArticleId IdType="pmc">PMC9869317</ArticleId><ArticleId IdType="pubmed">36690792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Badier N., Zhang L., Elb&#xe9;ji A., Wilmes P., Oustric P., Benoy C., Ollert M., Fagherazzi G. Long COVID Classification: Findings from a Clustering Analysis in the Predi-COVID Cohort Study. Int. J. Environ. Res. Public Health. 2022;19:16018. doi: 10.3390/ijerph192316018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316018</ArticleId><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="pubmed">36498091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., McCann K., O&#x2019;brien C., Savinelli S., Tinago W., Yousif O., Lambert J.S., O&#x2019;broin C., Feeney E.R., De Barra E., et al. Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open Forum Infect. Dis. 2022;9:ofac060. doi: 10.1093/ofid/ofac060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T., Borzikowsky C., Lieb W., Horn A., Krist L., Fricke J., Scheibenbogen C., Rabe K.F., Maetzler W., Maetzler C., et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. Eclinicalmedicine. 2022;51:101549. doi: 10.1016/j.eclinm.2022.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Thorpe L.E., Simon N.M., de Havenon A., Yaghi S., Sabadia S.B., Yang D., Lewis A., Melmed K., Balcer L.J., et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study. PLoS ONE. 2022;17:e0275274. doi: 10.1371/journal.pone.0275274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275274</ArticleId><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisiel M.A., Janols H., Nordqvist T., Bergquist J., Hagfeldt S., Malinovschi A., Svartengren M. Predictors of post-COVID-19 and the impact of persistent symptoms in non-hospitalized patients 12 months after COVID-19, with a focus on work ability. Upsala J. Med. Sci. 2022;127 doi: 10.48101/ujms.v127.8794.</Citation><ArticleIdList><ArticleId IdType="doi">10.48101/ujms.v127.8794</ArticleId><ArticleId IdType="pmc">PMC9383047</ArticleId><ArticleId IdType="pubmed">35991464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisiel M.A., Nordqvist T., Westman G., Svartengren M., Malinovschi A., Janols H. Patterns and predictors of sick leave among Swedish non-hospitalized healthcare and residential care workers with COVID-19 during the early phase of the pandemic. PLoS ONE. 2021;16:e0260652. doi: 10.1371/journal.pone.0260652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260652</ArticleId><ArticleId IdType="pmc">PMC8659339</ArticleId><ArticleId IdType="pubmed">34882720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon J.A., Garcia-Milian R., Norton H.F., Tennant M.R. The Use of Research Electronic Data Capture (REDCap) Software to Create a Database of Librarian-Mediated Literature Searches. Med. Ref. Serv. Q. 2014;33:241&#x2013;252. doi: 10.1080/02763869.2014.925379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02763869.2014.925379</ArticleId><ArticleId IdType="pmc">PMC4339087</ArticleId><ArticleId IdType="pubmed">25023012</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO/ISARIC, COVID-19 Case Record form. Global COVID-19 Clonical Platform. Novel Coronavirus COVID-19 Rapid Version. 2020.  [(accessed on 21 May 2023)].  Available online:  https://apps.who.int/iris/handle/10665/331768.</Citation></Reference><Reference><Citation>Sun X.M.D.F., Puzniak L., Coetzer H., Zamparo J.M., Tabak Y.P., Cappeller J.C. Assessment of Retrospective Collection of EQ-5D-5L in US Patients with COVID-19 in 2023.  [(accessed on 21 May 2023)].  Available online:  https://www.medrxiv.org/content/10.1101/2023.01.18.23284602v1.full.pdf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.18.23284602v1.full.pdf</ArticleId><ArticleId IdType="pmc">PMC10486034</ArticleId><ArticleId IdType="pubmed">37679771</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team R: A Language and Environment for Statistical Computing. V. R Foundation for Statistical Computing, Austria. 2023.  [(accessed on 21 May 2023)].  Available online:  https://www.R-project.org/</Citation></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B Methodol. 1995;57:289&#x2013;300. doi: 10.1111/j.2517-6161.1995.tb02031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hand D.J., Till R.J. A Simple Generalisation of the Area Under the ROC Curve for Multiple Class Classification Problems. Mach. Learn. 2001;45:171&#x2013;186. doi: 10.1023/A:1010920819831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1010920819831</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin M.R., Mehta A., Schneider A.M., Kays K.R., Guess J.R., Gentili M., Fenyves B.G., Charland N.C., Gonye A.L., Gushterova I., et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep. Med. 2021;2:100287. doi: 10.1016/j.xcrm.2021.100287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100287</ArticleId><ArticleId IdType="pmc">PMC8091031</ArticleId><ArticleId IdType="pubmed">33969320</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber N.H., Kohn J.N., Ogan W.S., Sitapati A., Longhurst C.A., Wang A., Lee S., Hong S., Horton L.E. Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care. Int. J. Environ. Res. Public Health. 2022;19:16841. doi: 10.3390/ijerph192416841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192416841</ArticleId><ArticleId IdType="pmc">PMC9778884</ArticleId><ArticleId IdType="pubmed">36554723</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Florencio L.L., Navarro-Pardo E., Rodr&#xed;guez-Jim&#xe9;nez J., Torres-Macho J., Pellicer-Valero O.J. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2022;51:61&#x2013;69. doi: 10.1007/s15010-022-01822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker H.R., Gulea C., Koteci A., Kallis C., Morgan A.D., Iwundu C., Weeks M., Gupta R., Quint J.K. GP consultation rates for sequelae after acute COVID-19 in patients managed in the community or hospital in the UK: Population based study. BMJ. 2021;375:e065834. doi: 10.1136/bmj-2021-065834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-065834</ArticleId><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson S.B., von Feilitzen G.S., Andersson M.E., Sikora P., Lindh M., Nord&#xe9;n R., Nilsson S., Sigstr&#xf6;m R. Self-reported symptom severity, general health, and impairment in post-acute phases of COVID-19: Retrospective cohort study of Swedish public employees. Sci. Rep. 2022;12:19818. doi: 10.1038/s41598-022-24307-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24307-1</ArticleId><ArticleId IdType="pmc">PMC9672032</ArticleId><ArticleId IdType="pubmed">36396860</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Giszas B., Trommer S., Sch&#xfc;&#xdf;ler N., Rodewald A., Besteher B., Bleidorn J., Dickmann P., Finke K., Katzer K., Lehmann-Pohl K., et al. Post-COVID-19 condition is not only a question of persistent symptoms: Structured screening including health-related quality of life reveals two separate clusters of post-COVID. Infection. 2022;51:365&#x2013;377. doi: 10.1007/s15010-022-01886-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01886-9</ArticleId><ArticleId IdType="pmc">PMC9307219</ArticleId><ArticleId IdType="pubmed">35869353</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>